RemeGen’s China Clinical Win In gMG Paves Way For Global Phase III

 
• By Dexter Jie Yan
Concept of Myasthenia Gravis written on sticky notes isolated on Wooden Table.
Telitacicept's domestic clinical win expected to accelerate global Phase III program for gMG • Source: Shutterstock

More from China

More from Focus On Asia